Literature DB >> 28137424

PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields.

Doodipala Samba Reddy1, Omkaram Gangisetty2, Xin Wu2.   

Abstract

Progesterone (P) binding to the intracellular progesterone receptors (PRs) plays a key role in epilepsy via modulation of GABA-A receptor plasticity in the brain. This is thought to occur via conversion of P to neurosteroids such as allopregnanolone, an allosteric modulator of GABA-A receptors. In the female brain, the composition of GABA-A receptors is not static and undergoes dynamic spatial changes in response to fluctuations in P and neurosteroid levels. Synaptic α2-containing GABA-A receptors contribute to phasic neuronal excitability and seizure susceptibility. However, the mechanisms underlying α2-subunit plasticity remain unclear. Here, we utilized the neurosteroid synthesis inhibitor finasteride and PR knockout mice to investigate the role of PRs in α2-subunit in the hippocampus. α2-Subunit expression was significantly upregulated during the high-P state of diestrous stage and with P treatment in wildtype and PR knockout mice. In contrast, there was no change in α2-subunit expression when metabolism of P into neurosteroids was blocked by finasteride in both genotypes. These findings suggest that ovarian cycle-related P and neurosteroids regulate α2-GABA-A receptor expression in the hippocampus via a non-PR pathway, which may be relevant to menstrual-cycle related brain conditions. Copyright Â
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy; GABA receptor; Neurosteroid; Perimenstrual; Progesterone; α2-Subunit

Mesh:

Substances:

Year:  2017        PMID: 28137424      PMCID: PMC5367384          DOI: 10.1016/j.brainres.2017.01.030

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  59 in total

Review 1.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

2.  Anxiolytic activity of progesterone in progesterone receptor knockout mice.

Authors:  Doodipala S Reddy; Bert W O'Malley; Michael A Rogawski
Journal:  Neuropharmacology       Date:  2005-01       Impact factor: 5.250

3.  Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform.

Authors:  A M Lavoie; J J Tingey; N L Harrison; D B Pritchett; R E Twyman
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

Review 4.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

5.  Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Authors:  Doodipala Samba Reddy; Omkaram Gangisetty; Seema Briyal
Journal:  Neuropharmacology       Date:  2010-09-08       Impact factor: 5.250

6.  Infusion of 3alpha,5alpha-THP to the pontine reticular formation attenuates PTZ-induced seizures.

Authors:  C A Frye; J Manjarrez; I Camacho-Arroyo
Journal:  Brain Res       Date:  2000-10-20       Impact factor: 3.252

7.  Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5alpha-reductase.

Authors:  Cheryl A Frye; Madeline E Rhodes; Alicia Walf; Jacob Harney
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

8.  Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats.

Authors:  D S Reddy; S K Kulkarni
Journal:  Pharmacol Biochem Behav       Date:  1999-01       Impact factor: 3.533

9.  Progesterone therapy in women with complex partial and secondary generalized seizures.

Authors:  A G Herzog
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

Review 10.  Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy.

Authors:  Doodipala Samba Reddy
Journal:  Front Cell Neurosci       Date:  2016-04-22       Impact factor: 5.505

View more
  6 in total

1.  3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-03-30       Impact factor: 4.030

2.  Does Stress Trigger Seizures? Evidence from Experimental Models.

Authors:  Doodipala Samba Reddy; Wesley Thompson; Gianmarco Calderara
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 3.  Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Authors:  Doodipala Samba Reddy
Journal:  J Neuroendocrinol       Date:  2021-09-10       Impact factor: 3.870

Review 4.  Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells.

Authors:  Peter Thomas; Yefei Pang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-24       Impact factor: 5.555

5.  Early-life adversity selectively impairs α2-GABAA receptor expression in the mouse nucleus accumbens and influences the behavioral effects of cocaine.

Authors:  Scott J Mitchell; Edward P Maguire; Linda Cunningham; Benjamin G Gunn; Matthias Linke; Ulrich Zechner; Claire I Dixon; Sarah L King; David N Stephens; Jerome D Swinny; Delia Belelli; Jeremy J Lambert
Journal:  Neuropharmacology       Date:  2018-08-21       Impact factor: 5.250

Review 6.  Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease.

Authors:  Ari Loren Mendell; Neil James MacLusky
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.